Cross-Border Investment - McDermott Will & Emery



Cross-border deals are complex and require mastery of multiple disciplines. That’s why collaboration is an integral part of our unique model. In addition to helping you get deals done across borders, we also advise on a variety of other areas impacting your business, including tax issues, management incentive plans, healthcare regulations, and multi-jurisdictional debt financing and restructuring.

With more than 150 dedicated private equity lawyers across 20 global offices, no matter where you are—physically or in the evolution of your business—we’re there with you.

This resource center will remain updated with the latest information impacting cross-border investment, including upcoming events, insights and resources, media coverage and more. Subscribe now to receive updates.


Creative Solutions Needed to Support Healthcare Investors Through Difficult Times, Private Equity News, November 7, 2022

Private Equity Healthcare Deals Face Slowdown But Obstacles Surmountable, Bankers Say, Mergermarket, October 25, 2022

HPE 2022: Financing Trends, Health Investor UK, October 20, 2022

Take-Privates The Best Hope For Direct Lenders to Keep Momentum, Bloomberg, October 10, 2022

MuMAC Special 2022, M&A Review, September 2022

European PE Sponsors Step Up to Meet Unprecedented Challenges, S&P Global Market Intelligence, August 8, 2022

Medical Microinstruments’ $75 Million Series B Round, Global Legal Chronicle, July 29, 2022

French E-Health and Biotech Attract Growing Investor Interest, Private Equity News, July 27, 2022

SAS Filing Heralds Fresh Restructuring Wave, International Financing Review, July 25, 2022